These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 19161308)
1. Total synthesis of photoactivatable or fluorescent anandamide probes: novel bioactive compounds with angiogenic activity. Balas L; Durand T; Saha S; Johnson I; Mukhopadhyay S J Med Chem; 2009 Feb; 52(4):1005-17. PubMed ID: 19161308 [TBL] [Abstract][Full Text] [Related]
2. High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. Li C; Xu W; Vadivel SK; Fan P; Makriyannis A J Med Chem; 2005 Oct; 48(20):6423-9. PubMed ID: 16190768 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. Cano C; Páez JA; Goya P; Serrano A; Pavón J; Rodríguez de Fonseca F; Suardíaz M; Martín MI Eur J Med Chem; 2009 Dec; 44(12):4889-95. PubMed ID: 19762126 [TBL] [Abstract][Full Text] [Related]
5. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors. Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Herradón E; Martín MI; López-Miranda V Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831 [TBL] [Abstract][Full Text] [Related]
7. Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Zoratti C; Kipmen-Korgun D; Osibow K; Malli R; Graier WF Br J Pharmacol; 2003 Dec; 140(8):1351-62. PubMed ID: 14645143 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands. Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of a potential photoactivatable anandamide analog. Balas L; Cascio MG; Di Marzo V; Durand T Bioorg Med Chem Lett; 2006 Jul; 16(14):3765-8. PubMed ID: 16682198 [TBL] [Abstract][Full Text] [Related]
10. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
11. Development of novel tail-modified anandamide analogs. Yao F; Li C; Vadivel SK; Bowman AL; Makriyannis A Bioorg Med Chem Lett; 2008 Nov; 18(22):5912-5. PubMed ID: 18723350 [TBL] [Abstract][Full Text] [Related]
12. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798 [TBL] [Abstract][Full Text] [Related]
13. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630 [TBL] [Abstract][Full Text] [Related]
14. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552 [TBL] [Abstract][Full Text] [Related]
15. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362 [TBL] [Abstract][Full Text] [Related]
16. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo. Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413 [TBL] [Abstract][Full Text] [Related]
17. Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. Ronco AM; Llanos M; Tamayo D; Hirsch S Pharmacology; 2007; 79(1):12-6. PubMed ID: 17114903 [TBL] [Abstract][Full Text] [Related]
18. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder. Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490 [TBL] [Abstract][Full Text] [Related]
19. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514 [TBL] [Abstract][Full Text] [Related]
20. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]